{"id":96955,"date":"2025-08-20T14:02:09","date_gmt":"2025-08-20T14:02:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/96955\/"},"modified":"2025-08-20T14:02:09","modified_gmt":"2025-08-20T14:02:09","slug":"alcon-cites-tariffs-and-soft-market-in-lowered-sales-outlook-shares-fall","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/96955\/","title":{"rendered":"Alcon Cites Tariffs And Soft Market In Lowered Sales Outlook, Shares Fall"},"content":{"rendered":"\n<p class=\"yf-1090901\">Swiss-American eye care firm Alcon Inc (NYSE:<a class=\"link \" href=\"http:\/\/finance.yahoo.com\/q?s=ALC\" data-ylk=\"slk:ALC;elm:context_link;itc:0;sec:content-canvas\" rel=\"nofollow noopener\" target=\"_blank\">ALC<\/a>) stock slumped on Wednesday after the company cut its 2025 outlook late on Tuesday, <a href=\"https:\/\/www.benzinga.com\/topic\/tariffs?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=47234121\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:citing increased tariff impact;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">citing increased tariff impact<\/a>.<\/p>\n<p class=\"yf-1090901\">The company forecasts a full-year gross tariff impact of around $100 million from <a href=\"https:\/\/www.benzinga.com\/pressreleases\/25\/05\/b45391336\/alcon-reports-first-quarter-2025-results-and-launches-transformational-change-in-ophthalmic-surger?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=47234121\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:$80 million expected previously;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">$80 million expected previously<\/a>.<\/p>\n<p class=\"yf-1090901\">Alcon\u00a0reported second-quarter sales of $2.58 billion, up 4% year over year, missing the consensus of $2.63 billion.<\/p>\n<p class=\"yf-1090901\">Also Read: <a href=\"https:\/\/www.benzinga.com\/m-a\/25\/08\/46856884\/alcon-expands-vision-correction-portfolio-with-staar-surgical-acquisition?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=47234121\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition<\/a><\/p>\n<p class=\"yf-1090901\">Surgical net sales, which include implantables, consumables, and equipment\/other, were $1.5 billion, an increase of 2% on a reported basis and 1% on a <a href=\"https:\/\/www.benzinga.com\/pressreleases\/25\/08\/b47221516\/alcon-reports-second-quarter-2025-results-launched-tryptyr-and-announced-acquisition-of-staar-surg?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=47234121\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:constant currency basis;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">constant currency basis<\/a>.<\/p>\n<p class=\"yf-1090901\">Implantables net sales were $456 million, a decrease of 2%, reflecting soft market conditions and competitive pressures.<\/p>\n<p class=\"yf-1090901\">Consumables net sales were $777 million, an increase of 6%. Excluding favorable currency impacts of 2%, consumables net sales increased by 4% in constant currency. Growth was led by vitreoretinal and cataract consumables, particularly in international markets, and price increases, and reflects soft market conditions.<\/p>\n<p class=\"yf-1090901\">Equipment\/other net sales of $222 million, down 1% constant currency, as declines in legacy equipment were partially offset by sales of the recently launched Unity VCS and Voyager DSLT devices.<\/p>\n<p class=\"yf-1090901\">Vision Care net sales, which include contact lenses and ocular health, were $1.1 billion, an increase of 6% on a reported basis and 5% on a constant currency.<\/p>\n<p class=\"yf-1090901\"><a href=\"https:\/\/www.benzinga.com\/stock\/ALC\/earnings\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:View more earnings on ALC;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">View more earnings on ALC<\/a><\/p>\n<p class=\"yf-1090901\">Contact lenses\u2019 net sales were $692 million, up 9% and 7% on constant currency, primarily driven by product innovation and price increases.<\/p>\n<p class=\"yf-1090901\">Ocular health net sales were $430 million, an increase of 2%, led by the portfolio of eye drops, partially offset by declines in contact lens care.<\/p>\n<p class=\"yf-1090901\">The company reported adjusted earnings of 76 cents per share, beating <a href=\"https:\/\/www.benzinga.com\/quote\/ALGN\/earnings?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=47234121\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:the consensus of 72 cents;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">the consensus of 72 cents<\/a>.<\/p>\n<p class=\"yf-1090901\">Alcon reported an operating margin of 9.6% in the second quarter, below last year\u2019s 12.8%.<\/p>\n<p class=\"yf-1090901\">\u201cAlcon is exiting the second quarter with solid momentum, despite a relatively soft surgical market in the first half of the year,\u201d said David J. Endicott, Alcon\u2019s Chief Executive Officer. \u201cRobust early demand for our recent product launches, including Unity VCS, Voyager, PanOptix Pro, Precision7, Systane Pro PF, and Tryptyr, has been encouraging. While it\u2019s still early, these launches position us to accelerate top-line growth, generate cash, and deliver long-term value for our shareholders.\u201d<\/p>\n<p class=\"yf-1090901\">Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15\u00a0<a href=\"https:\/\/www.benzinga.com\/calendars\/earnings?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=47234121\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:versus consensus of\u00a0$3.12;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">versus consensus of\u00a0$3.12<\/a>.<\/p>\n<p class=\"yf-1090901\">The company lowered 2025 sales\u00a0guidance\u00a0from\u00a0$10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, versus the consensus of $10.48 billion.<\/p>\n","protected":false},"excerpt":{"rendered":"Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook&hellip;\n","protected":false},"author":2,"featured_media":96956,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[65508,28,65509,112,2215],"class_list":["post-96955","post","type-post","status-publish","format-standard","has-post-thumbnail","category-markets","tag-alcon-inc","tag-business","tag-consumables","tag-markets","tag-reported-basis"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/96955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=96955"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/96955\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/96956"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=96955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=96955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=96955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}